The Michael J Fox Foundation for Parkinson’s Research invites pre-applications for its improved biomarkers and clinical outcome measures programme. This supports research that develops biomarker tools and clinical outcome measures to assist in target validation for therapeutic development and ultimately inform clinical trial design, execution and interpretation of results. Projects should seek to develop or optimise imaging, clinical, non-invasive or biochemical biomarkers to improve the precision of measuring Parkinson’s disease in humans.
Proposals should fall into one of the following categories:
- imaging studies;
- clinical or non-invasive physiological studies;
- biochemical assays and outcome measures;
- data science.
Funding & Duration
Grants are worth up to USD $750,000 each (approx. AUD $1.015M) for between one and three years.
Applications may be submitted by researchers or clinicians in:
- U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
- U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
- Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative principal investigator who directs the laboratory in which the fellow will conduct research. The administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not be considered.
Submission Requirements & Due Dates
- 26 September 2018 – Pre-Proposals submitted to Sponsor.
- 15 January 2019 – full applications submitted for internal review.
- Please complete your RFR through ResearchMaster > Fund Scheme code ORG122461
- See also: Submitting an Application to Research Services for Review